Results
In the systematic review, 19,998 patients were included from 6 randomized trials (n¼4,342) and 31 observational studies (n¼ 15,656) . The pooled analysis demonstrated a 23% reduction in the risk of mortality in patients treated with early goal-directed therapy (relative risk¼0.77; 95% confidence interval 0.71 to 0.83; 
STUDY SELECTION
Randomized and observational nonrandomized studies evaluating early goal-directed therapy in patients with severe sepsis or septic shock with reported mortality outcomes were selected. Studies were excluded if mortality data were not provided, mortality data could not be collected separately for patients who received early goal-directed therapy in conjunction with other sepsis bundles, early goal-directed therapy was used in both study arms, or studies were published before January 2001. If a published abstract met the study inclusion criteria but no article was published or available, then the results were excluded from the main analysis but included in sensitivity analysis.
DATA EXTRACTION AND ANALYSIS
The 4 authors collected multiple predefined variables from all of the studies and used 3 levels of analysis to determine the results. In the first P<.001). This reduction was not observed in the randomized studies (relative risk¼0.92; 95% confidence interval 0.78 to 1.07; P¼.27). A meta-regression analysis of potential differences between the randomized and the observational studies revealed that the only factors associated with the mortality differences between early goal-directed therapy and control were the following: time to first antibiotic, and antibiotic administration within 6, 4, and 3 hours (Table 1) . There was an association between Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential [Sepsis-related] Organ Failure Assessment (SOFA) scores and increased mortality in patients treated with early goal-directed therapy (Table 2) .
Sensitivity analysis on the quality of included studies based on the Newcastle-Ottawa Scale showed results similar to the overall mortality outcome results (relative risk¼0
Limitations of the systematic review, such as changes in clinical practice over time, flaws related to the design of each study, and missing unknown factors, were mentioned. Issues such as data aggregation, the lack of individual patient data, and the heterogeneity of the analyses were also discussed.
Commentary
This study attempts to explain the discordance between the significant survival benefits of the original early goal-directed therapy trial 1 and more recent randomized trials demonstrating inconsistent outcomes. [2] [3] [4] A recent metaanalysis of 3 major governmentfunded, multicenter, randomized, controlled trials (Protocol-based Care for Early Sepsis, Australasian Resuscitation in Early Sepsis Evaluation, and Protocolized Management in Sepsis) resulted in no better outcomes from early goal-directed therapy than usual care. 5 The results of this systematic review indicate that the survival discordance noted between observational and randomized controlled trials of early goaldirected therapy was not a result of early goal-directed therapy bundle compliance or achievement of hemodynamic target parameters, but rather of rapid and efficacious antibiotic therapy for sepsis. This finding has significant face validity, given the accepted biological rationale for the effect of antibiotics on sepsis. The results of this review further demonstrate a 10% increase in the relative risk of mortality for every hour of delay in antibiotic administration among patients with severe sepsis or septic shock.
The review findings also indicate that the discrepancies in the relative risk of mortality may have been due to the original studies' designs (randomized versus observational). The hemodynamic support and other nonantibiotic interventions linked with the sizable mortality decrease in the early goal-directed therapy patients in observational trials were not repeated in the randomized studies because these same nonantibiotic interventions were spread equally among early goaldirected therapy and control patients in the randomized trials.
The authors of this review also noted that early goal-directed therapy may have been associated with greater relative risk of mortality in patients with more severe sepsis (elevated APACHE II and SOFA scores, or the presence step, random-effects analysis was used to determine the pooled mortality outcomes of all trials, as well as the separate mortality outcomes for randomized and nonrandomized trials. In the second step, because of variability between the included trials and differences of study populations, 3 levels of Bayesian hierarchic regression analysis were used to account for differences within trials (first level), between trials (second level), and between differing study designs (third level). Because of the possibility of selection bias in the nonrandomized trials, a standard Bayesian analysis was also used on randomized trials using various priors (6 total priors were defined). This analysis was to statistically account for the evidence that existed when each trial was conducted. In the final step, the authors conducted a subgroup random-effects regression analysis of baseline and variable factors, and determined the relative risk for the primary outcome of hospital mortality.
of shock). They posited that the early goal-directed therapy approach indiscriminately applied may be harmful to patients lacking the hemodynamic reserve for such resuscitation. 
